| SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ... Nature immunology 22 (1), 74-85, 2021 | 590 | 2021 |
| A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity JS Heitmann, T Bilich, C Tandler, A Nelde, Y Maringer, M Marconato, ... Nature 601 (7894), 617-622, 2022 | 181 | 2022 |
| T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals T Bilich, A Nelde, JS Heitmann, Y Maringer, M Roerden, J Bauer, J Rieth, ... Science translational medicine 13 (590), eabf7517, 2021 | 153 | 2021 |
| mTOR regulates endocytosis and nutrient transport in proximal tubular cells F Grahammer, SK Ramakrishnan, MM Rinschen, AA Larionov, M Syed, ... Journal of the American Society of Nephrology 28 (1), 230-241, 2017 | 95 | 2017 |
| mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress F Grahammer, N Haenisch, F Steinhardt, L Sandner, M Roerden, F Arnold, ... Proceedings of the National Academy of Sciences 111 (27), E2817-E2826, 2014 | 95 | 2014 |
| The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy T Bilich, A Nelde, L Bichmann, M Roerden, HR Salih, DJ Kowalewski, ... Blood, The Journal of the American Society of Hematology 133 (6), 550-565, 2019 | 68 | 2019 |
| The immune checkpoint modulator OX40 and its ligand OX40L in NK-cell immunosurveillance and acute myeloid leukemia T Nuebling, CE Schumacher, M Hofmann, I Hagelstein, BJ Schmiedel, ... Cancer Immunology Research 6 (2), 209-221, 2018 | 59 | 2018 |
| Preexisting and post–COVID-19 immune responses to SARS-CoV-2 in patients with cancer T Bilich, M Roerden, Y Maringer, A Nelde, JS Heitmann, ML Dubbelaar, ... Cancer discovery 11 (8), 1982-1995, 2021 | 38 | 2021 |
| CD105 (Endoglin) as negative prognostic factor in AML J Kauer, K Schwartz, C Tandler, C Hinterleitner, M Roerden, G Jung, ... Scientific reports 9 (1), 18337, 2019 | 29 | 2019 |
| Immunopeptidomics-guided warehouse design for peptide-based immunotherapy in chronic lymphocytic leukemia A Nelde, Y Maringer, T Bilich, HR Salih, M Roerden, JS Heitmann, ... Frontiers in immunology 12, 705974, 2021 | 26 | 2021 |
| Neoantigens in hematological malignancies—Ultimate targets for immunotherapy? M Roerden, A Nelde, JS Walz Frontiers in immunology 10, 501237, 2019 | 21 | 2019 |
| Identification of CD318 (CDCP1) as novel prognostic marker in AML JS Heitmann, I Hagelstein, C Hinterleitner, M Roerden, G Jung, HR Salih, ... Annals of Hematology 99, 477-486, 2020 | 19 | 2020 |
| HLA evolutionary divergence as a prognostic marker for AML patients undergoing allogeneic stem cell transplantation M Roerden, A Nelde, JS Heitmann, R Klein, HG Rammensee, WA Bethge, ... Cancers 12 (7), 1835, 2020 | 17 | 2020 |
| Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma T Bilich, A Nelde, J Bauer, S Walz, M Roerden, HR Salih, K Weisel, ... Blood cancer journal 10 (2), 24, 2020 | 17 | 2020 |
| Expression of the immune checkpoint modulator OX40 in acute lymphoblastic leukemia is associated with BCR-ABL positivity K Rothfelder, I Hagelstein, M Roerden, G Blumenstock, M Hofmann, ... Neoplasia 20 (11), 1150-1160, 2018 | 16 | 2018 |
| The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience M Roerden, JS Walz, MR Müller, M Sökler, B Federmann, L Kanz, ... Journal of Cancer Research and Clinical Oncology 145, 2595-2604, 2019 | 14 | 2019 |
| Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience M Roerden, M Sökler, L Kanz, W Bethge, W Vogel, JS Walz Annals of Hematology 99 (2), 265-276, 2020 | 9 | 2020 |
| Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies M Roerden, R Döffinger, G Barcenas-Morales, S Forchhammer, S Döbele, ... BMC Infectious Diseases 20, 1-5, 2020 | 8 | 2020 |
| SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ... Research Square, DOI 10, 2020 | 8 | 2020 |
| DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts A Goyal, J Bauer, J Hey, DN Papageorgiou, E Stepanova, M Daskalakis, ... Nature communications 14 (1), 6731, 2023 | 5 | 2023 |
